Linde Peter 4
4 · Morphic Holding, Inc. · Filed Jan 19, 2021
Insider Transaction Report
Form 4
Linde Peter
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy Common Stock)
2021-01-15+83,000→ 83,000 totalExercise: $30.19Exp: 2031-01-14→ Common Stock (83,000 underlying)
Footnotes (1)
- [F1]The option vests as to 2.0833% of the total shares monthly, beginning February 15, 2021, with 100% of the total shares vested and exercisable on January 15, 2025, subject to the reporting person's provision of service to the issuer on each vesting date.